NC
TEVA icon

Northern Cross’s Teva Pharmaceuticals TEVA Stock Holding History

Northern Cross’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$18.5M Sell
860,538
-21,640,266
-96% -$502M 6.64% 5
2018
Q2 		$547M Sell
22,500,804
-1,998,421
-8% -$40.8M 9.66% 5
2018
Q1 		$419M Buy
24,499,225
+2,304,437
+10% +$45M 6.88% 6
2017
Q4 		$421M Sell
22,194,788
-569,597
-3% -$8.57M 5.46% 6
2017
Q3 		$401M Buy
22,764,385
+4,968,806
+28% +$112M 5.16% 6
2017
Q2 		$591M Buy
17,795,579
+2,184,172
+14% +$67.6M 7.62% 6
2017
Q1 		$501M Buy
+15,611,407
New +$533M 6.8% 6

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM